Chemours Co

For the period ended Mar 31, 2026. Filed May 5, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 5, 2026

CC$13.48+1.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Interim Consolidated Balance Sheets (Unaudited)

	March 31, 2026	December 31, 2025
Assets
Current assets:
Cash and cash equivalents	$563	$670
Restricted cash and restricted cash equivalents	—	2
Accounts and notes receivable, net	759	679
Inventories	1,536	1,569
Prepaid expenses and other	69	80
Assets held for sale	1	1
Total current assets	2,928	3,001
Property, plant, and equipment	9,925	9,920
Less: Accumulated depreciation	(6,885)	(6,842)
Property, plant, and equipment, net	3,040	3,078
Operating lease right-of-use assets	274	271
Goodwill	46	46
Other intangible assets, net	2	2
Investments in affiliates	166	160
Assets held for sale, non-current	21	21
Restricted cash and restricted cash equivalents	52	52
Other assets	738	751
Total assets	$7,267	$7,382
Liabilities
Current liabilities:
Accounts payable	$891	$954
Compensation and other employee-related cost	122	96
Short-term and current maturities of long-term debt	37	42
Current environmental remediation	97	88
Other accrued liabilities	462	506
Total current liabilities	1,609	1,686
Long-term debt, net	4,100	4,099
Operating lease liabilities	192	191
Long-term environmental remediation	520	530
Deferred income taxes	40	37
Other liabilities	590	588
Total liabilities	7,051	7,131
Commitments and contingent liabilities
Equity
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 199,180,562 shares issued and 150,355,228 shares outstanding at March 31, 2026; 198,720,786 shares issued and 149,893,993 shares outstanding at December 31, 2025)	2	2
Treasury stock, at cost (48,825,334 shares at March 31, 2026 and 48,826,793 at December 31, 2025)	(1,802)	(1,802)
Additional paid-in capital	1,081	1,074
Retained earnings	1,178	1,220
Accumulated other comprehensive loss	(244)	(244)
Total Chemours stockholders’ equity	215	250
Non-controlling interests	1	1
Total equity	216	251
Total liabilities and equity	$7,267	$7,382

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.